Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.
- DOI
- 10.1016/s1470-2045(26)00216-0
- Published
- 2026-07-01
- Container
- Lancet Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-26-00216-0,
title = {Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.},
author = {Mauritz AJW and de Munck L and Simons JM and Verloop J and van Dalen T and Elkhuizen PHM and Scholten A and Houben RMA and van Leeuwen-Stok AE and Linn SC and Pijnappel RM and Poortmans PMP and Strobbe LJA and Wesseling J and Voogd AC and Boersma LJ.},
year = {2026},
journal = {Lancet Oncol},
doi = {10.1016/s1470-2045(26)00216-0},
url = {https://doi.org/10.1016/s1470-2045(26)00216-0}
}RIS
TY - JOUR TI - Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study. AU - Mauritz AJW AU - de Munck L AU - Simons JM AU - Verloop J AU - van Dalen T AU - Elkhuizen PHM AU - Scholten A AU - Houben RMA AU - van Leeuwen-Stok AE AU - Linn SC AU - Pijnappel RM AU - Poortmans PMP AU - Strobbe LJA AU - Wesseling J AU - Voogd AC AU - Boersma LJ. PY - 2026 JO - Lancet Oncol DO - 10.1016/s1470-2045(26)00216-0 UR - https://doi.org/10.1016/s1470-2045(26)00216-0 ER -
APA
AJW, M., L, D. M., JM, S., J, V., T, V. D., PHM, E., A, S., RMA, H., AE, V. L., SC, L., RM, P., PMP, P., LJA, S., J, W., AC, V., & LJ., B. (2026). Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.. Lancet Oncol. https://doi.org/10.1016/s1470-2045(26)00216-0
Source records
- europe-pmc · retrieved 2026-09-26T03:56:10.054Z